The Negative Effects of Continuous Infusion on Mortality and Emergence of Drug Resistant Bacteria

Continuous versus intermittent administration of meropelan, reduced mortality or emergence of drug resistant bacteria in critically patients with substance or septic shock? The answer is no. This is definitely the take-home message. I love this Congress because it does not decodumise into positive or negative. But definitely this is a neutral trial with minimal, minimal direction going into the right direction but they have not even trends. And tonight with the help of Yuki Kotani sitting here, we have updated the Lancet metanalizae over a few years ago,. adding this trial, which has a 70% weight in terms of patients, in terms of mortality and the significance of the metan